Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Omeprazole
Therapeutic Area : Gastroenterology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
PL Developments Gains FDA Nod for Omeprazole ANDA, Completes Debt Refinancing
Details : The FDA has approved PLD's Omeprazole Magnesium Tablet, a generic equivalent to Prilosec OTC for the treatment in adults of duodenal ulcer and gastric ulcer.
Brand Name : Prilosec-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
October 28, 2024
Lead Product(s) : Omeprazole
Therapeutic Area : Gastroenterology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?